Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?

• 1 April 2003
• journal article
• review article
• Published by Elsevier in Seminars in Clinical Neuropsychiatry
• Vol. 8  (2) , 94-108
• https://doi.org/10.1053/scnp.2003.50009

Abstract

Keywords

• SCHIZOPHRENIA
• NOVEL CLASS
• DOPAMINE
• RECEPTOR AGONISTS
• MECHANISM OF ACTION
• ANTIPSYCHOTIC DRUGS
• NEUROTENSIN
• LIABILITY